Diane Stroehmann - Net Worth and Insider Trading

Diane Stroehmann Net Worth

The estimated net worth of Diane Stroehmann is at least $12 dollars as of 2024-06-05. Diane Stroehmann is the See Remarks of Sienna Biopharmaceuticals Inc and owns about 124,724 shares of Sienna Biopharmaceuticals Inc (SNNAQ) stock worth over $12. Details can be seen in Diane Stroehmann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Diane Stroehmann has not made any transactions after 2017-08-01 and currently still holds the listed stock(s).

Transaction Summary of Diane Stroehmann

To

Diane Stroehmann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Diane Stroehmann owns 1 companies in total, including Sienna Biopharmaceuticals Inc (SNNAQ) .

Click here to see the complete history of Diane Stroehmann’s form 4 insider trades.

Insider Ownership Summary of Diane Stroehmann

Ticker Comapny Transaction Date Type of Owner
SNNAQ Sienna Biopharmaceuticals Inc 2019-07-02 See Remarks

Diane Stroehmann Latest Holdings Summary

Diane Stroehmann currently owns a total of 1 stock. Diane Stroehmann owns 124,724 shares of Sienna Biopharmaceuticals Inc (SNNAQ) as of August 1, 2017, with a value of $12.

Latest Holdings of Diane Stroehmann

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SNNAQ Sienna Biopharmaceuticals Inc 2017-08-01 124,724 0.00 12

Holding Weightings of Diane Stroehmann


Diane Stroehmann Form 4 Trading Tracker

According to the SEC Form 4 filings, Diane Stroehmann has made a total of 0 transactions in Sienna Biopharmaceuticals Inc (SNNAQ) over the past 5 years. The most-recent trade in Sienna Biopharmaceuticals Inc is the acquisition of 7,000 shares on August 1, 2017, which cost Diane Stroehmann around $105,000.

Insider Trading History of Diane Stroehmann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Diane Stroehmann Trading Performance

GuruFocus tracks the stock performance after each of Diane Stroehmann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Diane Stroehmann is -3.77%. GuruFocus also compares Diane Stroehmann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Diane Stroehmann within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Diane Stroehmann's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Diane Stroehmann

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.66 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 18.65 LIMIT LIMIT LIMIT LIMIT LIMIT

Diane Stroehmann Ownership Network

Ownership Network List of Diane Stroehmann

No Data

Ownership Network Relation of Diane Stroehmann

Insider Network Chart

Diane Stroehmann Owned Company Details

What does Sienna Biopharmaceuticals Inc do?

Who are the key executives at Sienna Biopharmaceuticals Inc?

Diane Stroehmann is the See Remarks of Sienna Biopharmaceuticals Inc. Other key executives at Sienna Biopharmaceuticals Inc include Chief Financial Officer Alexander Azoy , Chief Medical Officer Paul F. Lizzul , and director & President & CEO Iii Frederick Beddingfield .

Sienna Biopharmaceuticals Inc (SNNAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sienna Biopharmaceuticals Inc Insider Transactions

No Available Data

Diane Stroehmann Mailing Address

Above is the net worth, insider trading, and ownership report for Diane Stroehmann. You might contact Diane Stroehmann via mailing address: 30699 Russell Ranch Road Suite 140 Westlake Village Ca 91362.

Discussions on Diane Stroehmann

No discussions yet.